ABDSEROTEC search AbDSerotec SDC1 products
includes other brands or spellings
|
| ih | | Serotec mouse anti-human CD138 antibody was used in immunohistochemistry to study the expression, localization, and functional activity of TL1A in inflammatory bowel disease. |
| ih | | Serotec mouse monoclonal syndecan-1 (CD138, MCA681H) antibody was used in immunohistochemistry to study NF1 expression during the early development of human epidermis. |
| ih | | Serotec Ltd. anti-CD138 antibody B-B4 was used in the paraffin sections from human aggressive lymphomas and in immunohistochemistry to study the effect of CD23 and CD40 on identifying prognostically favorable subgroups of diffuse large B-cell lymphoma. |
| ih | | Serotec mouse antihuman syndecan-1 ectodomain antibody CD138 (clone B-B4) was used in immunohistochemistry to study the distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. |
BD BIOSCIENCES search BD Biosciences SDC1 products
includes other brands or spellings
|
| flow | | BD Biosciences biotinylated anti-CD138/syndecan1 antibody (clone 281-2) was used in flow cytometry to study identification of proteoglycans as the APRIL-specific binding partners.. |
MILTENYI BIOTEC search Miltenyi Biotec SDC1 products
|
| flow | | Miltenyi Biotec murine monoclonal PE anti-CD138 antibody was used in human myeloma cell lines and in flow cytometry to study the role for polyclonal rabbit antithymocyte globulin in apoptosis and complement-mediated lysis of myeloma cells. |
BECKMAN COULTER search Beckman Coulter SDC1 products
includes other brands or spellings
|
| ih | | DakoCytomation antibody against CD138 (clone MI15) was used in immunohistochemistry to investigate PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. |
| ih | | DAKO monoclonal CD138 antibody (clone MI15) was used in immunohistochemistry to detect CD138 expression in human primary mediastinal (thymic) B-cell lymphoma (PMBL). |
Articles Reviewed |
| 1. Maria Malminen et al. Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. 2002 |
| 2. Stefano A Pileri et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. 2003 |
| 3. Johan Linderoth et al. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. 2003 |
| 4. Giorgos Bamias et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. 2003 |
| 5. E June Davies et al. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. 2004 |
| 6. Karine Ingold et al. Identification of proteoglycans as the APRIL-specific binding partners. 2005 |
| 7. Martin S Zand et al. Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. 2006 |
| 8. José-Francisco Garcia et al. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. 2006 |